Ginkgo biloba and several other therapies offer modest cognitive benefits in vascular cognitive impairment, but heterogeneous evidence limits certainty.
A recent study supports the clinical utility of p-tau217 for the detection of preclinical stage Alzheimer disease pathology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback